SINUS CANCER

Clinical trials for SINUS CANCER explained in plain language.

Never miss a new study

Get alerted when new SINUS CANCER trials appear

Sign up with your email to follow new studies for SINUS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to shrink Hard-to-Treat head and neck tumors

Disease control Recruiting now

This study tests whether combining two drugs, sacituzumab govitecan and cetuximab, can shrink tumors in people with advanced head and neck cancer that has returned or spread after initial treatment. About 40 adults whose cancer worsened after first-line therapy will receive the c…

Matched conditions: SINUS CANCER

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 17, 2026 04:27 UTC

SINUS CANCER

Get alerted when new SINUS CANCER trials appear

New drug combo aims to shrink Hard-to-Treat head and neck tumors